全文获取类型
收费全文 | 1366篇 |
免费 | 117篇 |
国内免费 | 7篇 |
专业分类
耳鼻咽喉 | 4篇 |
儿科学 | 60篇 |
妇产科学 | 26篇 |
基础医学 | 156篇 |
口腔科学 | 38篇 |
临床医学 | 194篇 |
内科学 | 293篇 |
皮肤病学 | 18篇 |
神经病学 | 85篇 |
特种医学 | 266篇 |
外科学 | 144篇 |
综合类 | 23篇 |
预防医学 | 49篇 |
眼科学 | 18篇 |
药学 | 49篇 |
中国医学 | 6篇 |
肿瘤学 | 61篇 |
出版年
2023年 | 12篇 |
2022年 | 12篇 |
2021年 | 26篇 |
2020年 | 9篇 |
2019年 | 17篇 |
2018年 | 33篇 |
2017年 | 21篇 |
2016年 | 31篇 |
2015年 | 27篇 |
2014年 | 40篇 |
2013年 | 35篇 |
2012年 | 47篇 |
2011年 | 32篇 |
2010年 | 43篇 |
2009年 | 64篇 |
2008年 | 48篇 |
2007年 | 27篇 |
2006年 | 31篇 |
2005年 | 32篇 |
2004年 | 24篇 |
2003年 | 30篇 |
2002年 | 32篇 |
2001年 | 27篇 |
2000年 | 23篇 |
1999年 | 27篇 |
1998年 | 55篇 |
1997年 | 56篇 |
1996年 | 66篇 |
1995年 | 49篇 |
1994年 | 46篇 |
1993年 | 50篇 |
1992年 | 25篇 |
1991年 | 15篇 |
1990年 | 20篇 |
1989年 | 43篇 |
1988年 | 36篇 |
1987年 | 35篇 |
1986年 | 37篇 |
1985年 | 30篇 |
1984年 | 17篇 |
1983年 | 12篇 |
1982年 | 24篇 |
1981年 | 15篇 |
1980年 | 8篇 |
1979年 | 7篇 |
1978年 | 7篇 |
1977年 | 15篇 |
1976年 | 16篇 |
1975年 | 18篇 |
1969年 | 4篇 |
排序方式: 共有1490条查询结果,搜索用时 296 毫秒
1.
P. Nowakowski K. Ziaja T. Ludyga W. Kuczmik G. Biolik P. wik D. Ziaja 《Diseases of the esophagus》2007,20(4):358-360
Esophageus or gaster resection in patients with malignant disease is still a treatment of choice. It is obvious that each surgical procedure in these patients carries some possibility of complications. Esophageo-gastric or esophageo-jejuno anastomosis has a 4-27% frequency of fistula occurrence. All these result in 65% mortality in cases of poorer prognosis. The aim of this paper is not to present all types of complications but to objectively analyse the usefulness of the covered stent placement in the treatment of anastomotic fistulas. We present six patients who were treated for postoperative fistula of esophageo-gastric anastomosis (1 case) or esophageo-jejuno anastomosis (5 cases). All patients were treated with stapler suture for digestive tract reconstruction after malignancy removal during the primary surgical procedure. Signs and symptoms of suture leak between 5-8 days post-surgery were observed. Conservative therapy was not effective. Thus a new method of treatment was employed - covered stent placement. The procedure was performed under X-ray control. In all treated patients there was change for the better and quick reduction of secretion from the fistulas was observed. All patients were discharged from the department after several days and all had survived at 30 days follow-up. Covered esophageal stent placement seems to be a safe and promising method of treatment for patients with anastomotic fistula which significantly reduces mortality and improves quality of live. Our experiences confirms that of other investigators. 相似文献
2.
3.
ME BURGE AM JOSHUA CM McNEIL R HUI MJ BOYER R ABRAHAM 《Asia-Pacific Journal of Clinical Oncology》2005,1(1):47-52
Background: Pemetrexed and cisplatin have recently been shown to significantly improve survival compared with cisplatin alone. However, there are only limited data reflecting teaching hospital experience outside a clinical trial. Pemetrexed has only been available in Australia on a restricted basis since 2002. We reviewed our experience of patients treated on the Australian ‘Special Access Scheme’ at three major thoracic oncology units. Methods: Charts were reviewed for all patients enrolled on the scheme. Data was extracted on age, World Health Organization (WHO) performance status, histology, prior therapy, time from diagnosis to starting pemetrexed, chemotherapy (pemetrexed alone or with a platinum), cycle number, response rate, actuarial progression‐free and overall survival. Doses were cisplatin 75 mg/m2 or carboplatin AUC = 5 and pemetrexed 500 mg/m2 every 21 days. Results: 52 patients (32 male and 20 female) were reviewed. Median age was 58 years and 88% were WHO 0–1. Histology included 54% epithelial, 17% biphasic (epithelial and sarcomatoid) and 21% undefined. The median time from diagnosis to administration of pemetrexed was 145 days. Sixty‐five percent had minimal surgical intervention with video assisted thoracoscopy, pleurodesis and biopsy, while 19% had received prior palliative radiation. Seventy‐one percent were chemotherapy naïve, the remaining 29% having received previous platinum and/or gemcitabine regimens. Twenty‐three percent had pemetrexed alone, 35% in combination with carboplatin and 42% with cisplatin. The median number of cycles was 4 (range 1–13). The response rate was 33%. No toxicity was observed in 20% grade 3–4 toxicity in 10% (majority nausea/vomiting). The median progression‐free and overall survival times from starting pemetrexed were 184 days and 298 days, respectively. Conclusions: Pemetrexed‐based regimens are safe and effective in a community setting in malignant mesothelioma. 相似文献
4.
Andrzej Nowakowski Lukasz Kubaszewski Przemys?aw Nawrot 《Chirurgia narzadów ruchu i ortopedia polska》2007,72(5):357-361
The most difficult in proper qualification of the patient with chronic low back pain for an operative treatment is determination of the chance for satisfactory result. The diversity of the pain eliciting structure in the spine influence the decision. In the paper we have analyzed patient where the operative treatment was considered. In 149 patients divided in two groups the (not being previously operated on the spine--group 1 and after spine surgery--group 2) the neuroradiological procedures were performed (sacral epidural block, facet injections, root injections of the lumbar spine). As the result of this procedure in 108 patients (72%) surgical intervention at that time was abandoned. Conclusion. In our opinion the neuroradiological diagnostic procedures should be mandatory in back pain management of the patient were operative treatment is considered. We present the modified algorithm in diagnostic procedure preceding the operation. 相似文献
5.
6.
7.
8.
9.
10.